Skip Main Navigation

Steven Gullans, PhD

Steven Gullans, PhD

Chief Executive Officer Gemphire Therapeutics

Dr. Gullans has broad experience across the life sciences industry including being a board director at Gemphire since 2016, prior to joining full-time 2018. Previously Dr. Gullans was Managing Director at Excel Venture Management, a Boston-based life sciences venture capital firm which he cofounded in 2008. At Excel he spearheaded many successful investments in a variety of therapeutics and diagnostics companies, including Cleveland HeartLab. Prior to Excel, Dr. Gullans was co-founder and CEO of RxGen, Inc. and Chief Scientific Officer at U.S. Genomics. Currently Dr. Gullans is a director and co-founder of Orionis Biosciences LLC, a biotech therapeutics company and a director of N-of-One Inc., an oncology diagnostics entity. He advises on innovation at the Cleveland Clinic and Partners HealthCare.

For nearly 20 years, Dr. Gullans was a faculty member at Harvard Medical School and Brigham and Women’s Hospital where he published more 130 research papers in many fields. Dr. Gullans is passionate about innovation and co-authored two books with Juan Enriquez, including “Evolving Ourselves,” a book that provides a sweeping tour of how humans are changing the course of evolution. Dr. Gullans has spoken globally including at TEDMED and TEDx. He received his Ph.D. from Duke University, post-doctoral training at Yale University, and his B.S. from Union College. He is an elected Fellow of the American Heart Association as well as the American Association for the Advancement of Science.

External Selection Committee (ESC)

End of main page content.